Catalyst Wire Dossier Catalyst Wire Dossier

BI-Sifrol

pramipexole · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI-Sifrol, covering 2013-10-31 to 2014-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

See pricing